• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Ensem Therapeutics to Present Data on PI3K? Inhibitor at SABCS

    BUSINESSWIRE

    Ensem to Present Preclinical Data on CDK2 Inhibitor at SABCS

    BUSINESSWIRE

    Ensem’s partner BeiGene doses first five patients in first-in-human phase 1 tria

    PHARMABIZ

    Ensem Therapeutics Announces CDK2 Inhibitor Enters Clinical Trials

    BUSINESSWIRE

    BeiGene to buy global rights to Ensem`s experimental cancer therapy

    REUTERS

    ENSEM Announces the Promotion of Shengfang Jin, PhD to President & CEO

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.